Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 18Neoplasms 14Breast Neoplasms 13Neuroendocrine Tumors 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasm Metastasis 6Stomach Neoplasms 5Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Multiple Myeloma 4Disease 4Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Mouth Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Head and Neck Neoplasms 3Glioma 3Esophageal Squamous Cell Carcinoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Cells, Circulating 2Nasopharyngeal Carcinoma 2Multiple Pulmonary Nodules 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Liver Neoplasms 2Leukemia 2

Interventions

zirconium-89-trastuzumab 1Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Cancer Metastases × Positron Emission Tomography Computed Tomography × Clear all
NCT02286843 2021-06-18

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

Memorial Sloan Kettering Cancer Center

Phase NA Completed
49 enrolled 8 charts
Breast

Breast Cancer Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡